CYC News: Further weakness as Cyclopharm (ASX:CYC) drops 13% this week, taking one-year losses to 59% - 13th Jun 2022, 8:26am

[annb0t]

The nature of investing is that you win some, and you lose some. And there's no doubt that Cyclopharm Limited (ASX:CYC) stock has had a really bad year. The share price is down a hefty 59% in that time. Longer term shareholders haven't suffered as badly, since the stock is down a comparatively less painful 27% in three years. Shareholders have had an even rougher run lately, with the share price down 32% in the last 90 days.

If the past week is anything to go by, investor sentiment for Cyclopha...

>>> Read more: Further weakness as Cyclopharm (ASX:CYC) drops 13% this week, taking one-year losses to 59%